Shortening the Alzheimer’s disease assessment scale cognitive subscale

Shortening the Alzheimer’s disease assessment scale cognitive subscale

Abstract Background A short yet reliable cognitive measure is needed that separates treatment and placebo for treatment trials for Alzheimer’s disease. Hence, we aimed to shorten the Alzheimer’s Disease Assessment Scale Cognitive Subscale (ADAS-Cog) and test its use as an efficacy measure. Metho...

Full description

Bibliographic Details
Main Authors: Stephen Z. Levine, Yair Goldberg, Anat Rotstein, Myrto Samara, Kazufumi Yoshida, Andrea Cipriani, Takeshi Iwatsubo, Stefan Leucht, Toshiaki A. Furukawa
Format: Article
Language:English
Published: Cambridge University Press 2024-01-01
Series:European Psychiatry
Subjects:
Alzheimer’s disease
assessment
clinical trials
cognition
item response theory
psychometric
Online Access:https://www.cambridge.org/core/product/identifier/S0924933824000142/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S0924933824000142/type/journal_article

Similar Items